Ozanimod (Zeposia)

Indications

Moderately to severely active UC in adults

Contraindications

Active malignancy; heart failure, stroke or unstable angina in previous six months; immunodeficiency; severe active infection. Use with caution in elderly patients; cerebrovascular disease; chronic obstructive pulmonary disease; severe respiratory disease; severe sleep aponoea; diabetes; risk factors for intection; uncontrolled high blood pressure; retinal disease; uveitis. Avoid during pregnancy and breasteeding and in severe hepatic impairment. | Potential side effects: Slow heartbeat; headache; high or low blood pressure; increased risk of infection; low white blood cell count; peripheral oedema

Preparations Available

Oral capsule

Quantity

Dose: Initially 0.23mg once daily on days 1–4, then increased to 0.46 mg once daily on days 5–7, then increased to 0.92 mg once daily from day 8

Sizes Available

0.23mg capsules (4), no price; 0.46mg (3), no price; 0.92mg (28), £1,373.00

Price

0.23mg capsules (4), no price; 0.46mg (3), no price; 0.92mg (28), £1,373.00

More on: Immunosuppressants